BLSM

$21.51-2.23%

BlossomHill Therapeutics, Inc.

Market Cap

$502M

Sector

Materials

Industry

N/A

Beta

—

Insufficient price history

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

13

recent articles

Velocity Score

27.08x

Current Rate (90d)

10543.33/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

5

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-10	2026-08-12	ORBIMED ADVISORS LLC	Director	Purchase	625.0K	$16.00	$10.00M	2.71M	View
2026-08-10	2026-08-10	Chen Bihua	Director	Purchase	312.5K	$16.00	$5.00M	3.61M	View
2026-08-10	2026-08-10	Keyes Jason A	Chief Financial Officer	Purchase	700	$16.00	$11K	700	View
2026-08-10	2026-08-10	Schmid John P.	Director	Purchase	6,000	$16.00	$96K	6,000	View
2026-08-10	2026-08-10	Liptak Vincent Paul	General Counsel	Purchase	2,200	$16.00	$35K	111.4K	View

1–5 of 6

1 / 2

Recent News

Primary Markets Group August IPO Update

SeekingAlpha · 2026-09-05

BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference

Yahoo · 2026-09-03

LifeSci Capital Initiates Coverage On BlossomHill Therapeutics with Outperform Rating, Announces Price Target of $32

Benzinga · 2026-09-01

Leerink Partners Initiates Coverage On BlossomHill Therapeutics with Outperform Rating, Announces Price Target of $36

Benzinga · 2026-09-01

Informational purposes only, not investment advice.